Ledger.Open graph →
SEC Form D · filed January 8, 2014

Aeglea BioTherapeutics Holdings, LLC

Offering
$9.5M
Sold
$5.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AUSTIN, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

David Lowe · Austin, TXExec · DirectorCharles York · Austin, TXExecArmen Shanafelt · Austin, TXDirectorGeorge Georgiou · Bahnofstrasse 22, V8DirectorHenry Skinner · Austin, TXDirectorWalter V. Klemp · Houston, TXExec · DirectorLee C. Stranathan · Houston, TXExec · DirectorChristopher C. Capelli · Houston, TXExec · DirectorSamuel C. Wagner · San Diego, CADirectorDimitrios N. Theofilopoulos · San Diego, CADirectorThomas E. Ichim · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗